245 related articles for article (PubMed ID: 27483926)
1. Thyrotropin-Releasing Hormone Loaded and Chitosan Engineered Polymeric Nanoparticles: Towards Effective Delivery of Neuropeptides.
Kaur S; Bhararia A; Sharma K; Mittal S; Jain R; Wangoo N; Sharma RK
J Nanosci Nanotechnol; 2016 May; 16(5):5324-32. PubMed ID: 27483926
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L
J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459
[TBL] [Abstract][Full Text] [Related]
3. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of biodegradable polymeric nanoparticles and their controlled drug delivery for tuberculosis.
Malathi S; Balasubramanian S
J Biomed Nanotechnol; 2011 Feb; 7(1):150-1. PubMed ID: 21485846
[TBL] [Abstract][Full Text] [Related]
5. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity.
Liu J; Qiu Z; Wang S; Zhou L; Zhang S
Biomed Mater; 2010 Dec; 5(6):065002. PubMed ID: 20924138
[TBL] [Abstract][Full Text] [Related]
6. Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles.
Yadav KS; Sawant KK
AAPS PharmSciTech; 2010 Sep; 11(3):1456-65. PubMed ID: 20842542
[TBL] [Abstract][Full Text] [Related]
7. Development of novel cationic chitosan-and anionic alginate-coated poly(D,L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol.
Sanna V; Roggio AM; Siliani S; Piccinini M; Marceddu S; Mariani A; Sechi M
Int J Nanomedicine; 2012; 7():5501-16. PubMed ID: 23093904
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects.
Tahara K; Yamamoto H; Hirashima N; Kawashima Y
Eur J Pharm Biopharm; 2010 Mar; 74(3):421-6. PubMed ID: 20034563
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
[TBL] [Abstract][Full Text] [Related]
10. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure.
McCarron PA; Donnelly RF; Marouf W
J Microencapsul; 2006 Aug; 23(5):480-98. PubMed ID: 16980271
[TBL] [Abstract][Full Text] [Related]
12. Chitosan film containing poly(D,L-lactic-co-glycolic acid) nanoparticles: a platform for localized dual-drug release.
Tada DB; Singh S; Nagesha D; Jost E; Levy CO; Gultepe E; Cormack R; Makrigiorgos GM; Sridhar S
Pharm Res; 2010 Aug; 27(8):1738-45. PubMed ID: 20521086
[TBL] [Abstract][Full Text] [Related]
13. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
Salama AH; Mahmoud AA; Kamel R
AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
[TBL] [Abstract][Full Text] [Related]
14. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes.
Cosco D; Federico C; Maiuolo J; Bulotta S; Molinaro R; Paolino D; Tassone P; Fresta M
Int J Nanomedicine; 2014; 9():2359-72. PubMed ID: 24876772
[TBL] [Abstract][Full Text] [Related]
16. Intracellular delivery of cysteine protease inhibitor cystatin by polymeric nanoparticles.
Cegnar M; Kos J; Kristl J
J Nanosci Nanotechnol; 2006; 6(9-10):3087-94. PubMed ID: 17048522
[TBL] [Abstract][Full Text] [Related]
17. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine.
Grabovac V; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2007 Jul; 33(7):767-74. PubMed ID: 17654025
[TBL] [Abstract][Full Text] [Related]
18. Enhanced efficacy of clindamycin hydrochloride encapsulated in PLA/PLGA based nanoparticle system for oral delivery.
Rauta PR; Das NM; Nayak D; Ashe S; Nayak B
IET Nanobiotechnol; 2016 Aug; 10(4):254-61. PubMed ID: 27463797
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
20. Modification of the release characteristics of estradiol encapsulated in PLGA particles via surface coating.
Enayati M; Stride E; Edirisinghe M; Bonfield W
Ther Deliv; 2012 Feb; 3(2):209-26. PubMed ID: 22834198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
